Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(5 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
Line 16: Line 18:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
|-
 +
|
 +
==== CHAPTER 2 (TUMOURS OF THE KIDNEY) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
Line 445: Line 468:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 3 (TUMOURS OF THE URINARY TRACT) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
Line 655: Line 699:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 4 (TUMOURS OF THE PROSTATE) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 731:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 
|Disease
 
|Disease
 
|
 
|
Line 775: Line 840:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
Line 820: Line 906:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 6 (TUMOURS OF THE TESTIS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 938:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,138: Line 1,245:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
Line 1,348: Line 1,476:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
+
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,370: Line 1,508:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
+
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,446: Line 1,595:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
Line 1,502: Line 1,672:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 10 (MESENCHYMAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,524: Line 1,704:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,666: Line 1,857:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
Line 1,711: Line 1,923:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 12 (MELANOCYTIC LESIONS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
+
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,733: Line 1,955:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
+
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,755: Line 1,987:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
+
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,766: Line 1,998:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
+
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,777: Line 2,009:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
−
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
+
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,799: Line 2,052:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
+
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,810: Line 2,063:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
+
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,821: Line 2,074:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
+
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,832: Line 2,085:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
+
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,843: Line 2,096:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
+
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,854: Line 2,107:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
+
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,865: Line 2,118:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Carney_complex|Carney complex]]
+
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,876: Line 2,140:
 
|
 
|
 
|-
 
|-
−
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
+
|[[MALE5:Carney_complex|Carney complex]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,886: Line 2,150:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
 
|}
 
|}

Latest revision as of 14:09, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (TUMOURS OF THE KIDNEY)
Clear cell renal cell carcinoma Disease
Multilocular cystic renal neoplasm of low malignant potential Disease
Renal papillary adenoma Disease
Papillary renal cell carcinoma Disease
Oncocytoma of the kidney Disease
Chromophobe renal cell carcinoma Disease
Other oncocytic tumours of the kidney Disease
Collecting duct carcinoma Disease
Clear cell papillary renal cell tumour Disease
Mucinous tubular and spindle cell carcinoma Disease
Tubulocystic renal cell carcinoma Disease
Acquired cystic disease-associated renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
Renal cell carcinoma NOS Disease
TFE3-rearranged renal cell carcinomas Disease
TFEB-altered renal cell carcinomas Disease
ELOC (formerly TCEB1)-mutated renal cell carcinoma Disease
Fumarate hydratase-deficient renal cell carcinoma Disease
Succinate dehydrogenase-deficient renal cell carcinoma Disease
ALK-rearranged renal cell carcinomas Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Mixed epithelial and stromal tumour of the kidney Disease
Paediatric cystic nephroma Disease
Classic angiomyolipoma / PEComa of the kidney Disease
Epithelioid angiomyolipoma / epithelioid PEComa of the kidney Disease
Renal haemangioblastoma Disease
Juxtaglomerular cell tumour Disease
Renomedullary interstitial cell tumour Disease
Ossifying renal tumour of infancy Disease
Congenital mesoblastic nephroma Disease
Rhabdoid tumour of the kidney Disease
Clear cell sarcoma of the kidney Disease
Nephrogenic rests Disease
Cystic partially differentiated nephroblastoma Disease
Nephroblastoma Disease
Germ cell tumours of the kidney Disease

CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
Urothelial papilloma Disease
Inverted urothelial papilloma Disease
Papillary urothelial neoplasm of low malignant potential Disease
Non-invasive papillary urothelial carcinoma, low-grade Disease
Non-invasive papillary urothelial carcinoma, high-grade Disease
Urothelial carcinoma in situ Disease
Invasive urothelial carcinoma Disease
Squamous papilloma of the urothelial tract Disease
Verrucous carcinoma of the bladder Disease
Pure squamous carcinoma of the urothelial tract Disease
Villous adenoma Disease
Adenocarcinoma NOS Disease
Urachal carcinoma Disease
Diverticular carcinoma Disease
Littre gland adenocarcinoma of the urethra Disease
Skene gland adenocarcinoma of the urethra Disease
Cowper gland adenocarcinoma of the urethra Disease
Clear cell adenocarcinoma of the urinary tract Disease
Endometrioid carcinoma of the urinary tract Disease

CHAPTER 4 (TUMOURS OF THE PROSTATE)
Prostatic cystadenoma Disease
High-grade prostatic intraepithelial neoplasia Disease
Intraductal carcinoma of the prostate Disease
Prostatic acinar adenocarcinoma Disease
Prostatic ductal adenocarcinoma Disease
Treatment-related neuroendocrine prostatic carcinoma Disease
Adenosquamous carcinoma of the prostate Disease
Squamous cell carcinoma of the prostate Disease
Adenoid cystic (basal cell) carcinoma of the prostate Disease
Prostatic stromal tumour of uncertain malignant potential Disease
Prostatic stromal sarcoma Disease

CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
Cystadenoma of the seminal vesicle Disease
Adenocarcinoma of the seminal vesicle Disease
Squamous cell carcinoma of the seminal vesicle Disease
Mixed epithelial and stromal tumour of the seminal vesicle Disease

CHAPTER 6 (TUMOURS OF THE TESTIS)
Germ cell neoplasia in situ Disease
Specific forms of intratubular germ cell neoplasia Disease
Gonadoblastoma Disease
Seminoma Disease
Embryonal carcinoma Disease
Yolk sac tumour, postpubertal-type Disease
Choriocarcinoma Disease
Placental site trophoblastic tumour Disease
Epithelioid trophoblastic tumour Disease
Cystic trophoblastic tumour Disease
Teratoma, postpubertal-type Disease
Teratoma with somatic-type malignancy Disease
Mixed germ cell tumours Disease
Regressed germ cell tumours Disease
Spermatocytic tumour Disease
Teratoma, prepubertal-type Disease
Yolk sac tumour, prepubertal-type Disease
Testicular neuroendocrine tumour, prepubertal-type Disease
Mixed teratoma and yolk sac tumour, prepubertal-type Disease
Leydig cell tumour Disease
Sertoli cell tumour Disease
Large cell calcifying Sertoli cell tumour Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Tumours in the fibroma thecoma group Disease
Mixed sex cord stromal tumour Disease
Signet ring stromal tumour Disease
Myoid gonadal stromal tumour Disease
Sex cord stromal tumour NOS Disease

CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
Serous cystadenoma Disease
Serous tumour of borderline malignancy Disease
Serous cystadenocarcinoma Disease
Mucinous cystadenoma Disease
Mucinous borderline tumour Disease
Mucinous cystadenocarcinoma Disease
Endometrioid tumours Disease
Clear cell adenocarcinoma Disease
Brenner tumour Disease
Adenoma of the collecting ducts and rete testis Disease
Adenocarcinoma of the collecting ducts and rete testis Disease
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Cystadenoma of the epididymis Disease
Papillary cystadenoma of the epididymis Disease
Adenocarcinoma of the epididymis Disease
Squamous cell carcinoma of the epididymis Disease
Melanotic neuroectodermal tumour of the epididymis Disease

CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
Condyloma acuminatum Disease
Penile intraepithelial neoplasia, HPV-associated Disease
Differentiated penile intraepithelial neoplasia, HPV-independent Disease
HPV-associated squamous cell carcinoma Disease
HPV-independent squamous cell carcinoma Disease
Squamous cell carcinoma NOS Disease
Penile adenosquamous and mucoepidermoid carcinomas Disease
Extramammary Paget disease Disease
Basal cell carcinoma of the scrotum Disease

CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
Well-differentiated neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Mixed neuroendocrine neoplasms Disease
Paraganglioma Disease

CHAPTER 10 (MESENCHYMAL TUMOURS)
The angiofibroma family of tumours Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myointimoma Disease
Myopericytoma Disease
Extrarenal PEComa Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Synovial sarcoma Disease
Extrarenal rhabdoid tumour Disease
Desmoplastic small round cell tumour Disease

CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
Extranodal marginal zone lymphoma of MALT Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
Juvenile xanthogranuloma Disease

CHAPTER 12 (MELANOCYTIC LESIONS)
Mucosal melanoma Disease

CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
Metastasis to the urinary tract Disease
Metastasis to the kidney Disease
Metastasis to the testis and paratestis Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Birt-Hogg-Dube syndrome Disease
Hereditary papillary renal carcinoma Disease
Hereditary leiomyomatosis and renal cell carcinoma syndrome Disease
Succinate dehydrogenase-deficient tumour syndromes Disease
BAP1 tumour predisposition syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
Tuberous sclerosis Disease
Genitourinary system and Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hereditary tumour syndromes associated with homologous recombination pathway mutations Disease
Carney complex Disease
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Retrieved from "https://ccga.io/index.php?title=MALE5:Volunteer_Assignments_and_Opportunities&oldid=15424"